Monitor for actual sales by the selling stockholders, particularly ARCH Venture Fund, Gates Frontier, and Explore Investments, as these could create downward pressure on the stock. The recent $25M in insider buying suggests confidence in the company's prospects despite this resale registration. The lack of proceeds to the company means this is purely a liquidity event for existing investors rather than a capital raise.
LYEL drugs
LYEL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 6 $21.69entry
- T+1 · 7mo ago +0.41%α +0.35% · $21.78
- T+5 · 7mo ago +14.34%α +10.20% · $24.80
- T+20 · 7mo ago −4.47%α −13.45% · $20.72
- T+60 · 5mo ago −40.20%α −53.67% · $12.97
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Lyell Immunopharma has filed an S-3 shelf registration to allow selling stockholders to resell 1,952,360 shares of common stock acquired in a private placement on March 6, 2026. The company will not receive any proceeds from these sales, which were originally purchased at $25.61 per share in a milestone closing. The registration enables liquidity for institutional investors including ARCH Venture Fund, Gates Frontier, and Explore Investments.
Key Financial Metrics
Key Facts
- S-3 filing registers 1,952,360 shares for resale by selling stockholders from a March 6, 2026 private placement
- Company will not receive any proceeds from the resale of these shares
- Shares were acquired at $25.61 per share in a milestone closing under a July 2025 Securities Purchase Agreement
- Selling stockholders include ARCH Venture Fund XIII, Euler Fund, Gates Frontier LLC, and Explore Investments LLC
- Registration fee of $5,200.99 calculated based on $19.29 per share (average of March 27, 2026 Nasdaq high/low)
- Company recently had $25M in insider buying over the past 30 days
Financial Impact
Potential dilution of 8.4% based on 23,328,390 shares outstanding, with maximum aggregate offering price of $37.66M
Risk Factors
- Potential share price pressure if selling stockholders liquidate positions
- Perception of negative sentiment despite company not receiving proceeds
- Concentration risk with four primary selling stockholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-142213 |
| Document: d122816dexfilingfees.htm | 0001193125-26-142213 |
| Document: d122816dex51.htm | 0001193125-26-142213 |
| Document: d122816dex231.htm | 0001193125-26-142213 |
| Document: 0001193125-26-142213-index-headers.html | 0001193125-26-142213 |
| Document: 0001193125-26-142213-index.html | 0001193125-26-142213 |
| Document: 0001193125-26-142213.txt | 0001193125-26-142213 |
Track record
21 reports on LYEL
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +17.99% at T+60 after the Jun 8, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago S-3 Neutral 3/10 Entry $14.30 Now $14.65 +2.45% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Bullish 6/10 Entry $14.30 to $14.65 Now $14.65 +2.45% ▲ +2.45% +4.36% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $16.86 to $15.64 Now $14.65 −13.11% ▼ −7.24% −6.88% vs SPY
- Nov 5, 202611d ago Insider Cluster Bullish 7/10 Entry $14.86 to $15.42 Now $14.65 −1.41% ▲ +3.77% +1.40% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.00 to $14.86 Now $14.65 −2.33% ▼ −0.93% −1.25% vs SPY
- Nov 4, 202612d ago 8-K Bearish 5/10 Entry $15.43 to $15.00 Now $14.65 +5.06% ▲ +2.79% −1.62% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.43 to $15.00 Now $14.65 −5.06% ▼ −2.79% +1.62% vs SPY
- Aug 25, 202611w ago Insider Cluster Neutral 4/10 Entry $14.80 to $14.61 Now $14.65 −1.01% ▼ −1.28% −1.94% vs SPY
- Jul 22, 202616w ago EFFECT Neutral 4/10 Entry $12.84 to $12.78 Now $14.65 +14.10% ▼ −0.47% +0.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers